- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
Patent holdings for IPC class A61K 31/7048
Total number of patents in this class: 4685
10-year publication summary
|
336
|
324
|
333
|
354
|
399
|
459
|
429
|
377
|
341
|
312
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Société des Produits Nestlé S.A. | 9901 |
71 |
| Boehringer Ingelheim International GmbH | 4636 |
64 |
| The Board of Trustees of the University of Illinois | 2724 |
39 |
| Suntory Holdings Limited | 2073 |
32 |
| Boehringer Ingelheim Vetmedica GmbH | 1274 |
31 |
| The Regents of the University of California | 20303 |
27 |
| Massachusetts Institute of Technology | 10150 |
25 |
| AMOREPACIFIC Corporation | 2852 |
25 |
| Insmed Incorporated | 248 |
24 |
| Korea Research Institute of Bioscience and Biotechnology | 1058 |
23 |
| Amazentis SA | 173 |
22 |
| Phoenix Biotechnology, Inc. | 48 |
22 |
| Evonik Operations GmbH | 4181 |
22 |
| RedHill Biopharma Ltd. | 98 |
21 |
| Zoetis Services LLC | 1533 |
21 |
| Novartis AG | 10612 |
19 |
| Wisconsin Alumni Research Foundation | 3894 |
18 |
| The Brigham and Women's Hospital, Inc. | 2227 |
18 |
| Boehringer Ingelheim Animal Health USA Inc. | 421 |
18 |
| Galderma Holding S.A. | 681 |
18 |
| Other owners | 4125 |